| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.01 |
| mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
0.4 |
0.01 |
| mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
0.38 |
0.01 |
| mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.02 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
| mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.02 |
| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
| mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.02 |